How big is the cancer biotherapy market?

Q: How big is the cancer biotherapy market?

Buyers of the report can access verified and reliable market forecasts including those for the overall size of the global Cancer Biotherapy market in terms of revenue.On the whole the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Biotherapy market.Cancer biotherapy is a form of treatment that uses the natural immune system to protect the body against cancer.Market Analysis and Insights Global Cancer Biotherapy MarketThe global Cancer Biotherapy market size is projected to reach US XX million by 2027 from US XX million in 2020 at a CAGR of XX during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Biotherapy market to help players in achieving a strong market position.

Global and United States Cancer Biotherapy Market Report & Forecast 2022-2028

Code: QYRE-Auto-18N5929

Report

June 2022

Pages:91

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Cancer biotherapy is a form of treatment that uses the natural immune system to protect the body against cancer.

Market Analysis and Insights: Global and United States Cancer Biotherapy Market

This report focuses on global and United States Cancer Biotherapy market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Cancer Biotherapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, by Type, Monoclonal Antibodies accounting for % of the Cancer Biotherapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Cancer Biotherapy market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Cancer Biotherapy Scope and Market Size

Cancer Biotherapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cancer Biotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Cancer Biotherapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Monoclonal Antibodies

Vaccines

Erythropoietin

Colony Stimulating Factors

Interleukins and Interferons

Segment by Application

Hospitals

Diagnostic Laboratories

Research and Academic Laboratories

Pharmaceutical and Biotechnology Companies

Others

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

BY COMPANY

Amgen

Bristol-Myers Squibb

Celgene

GlaxoSmithKline

Eli Lilly

FEATURED COMPANIES

1 Study Coverage

1.1 Cancer Biotherapy Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Introduction

1.2 Global Cancer Biotherapy Outlook 2017 VS 2022 VS 2028

1.2.1 Global Cancer Biotherapy Market Size for the Year 2017-2028

1.2.2 Global Cancer Biotherapy Market Size for the Year 2017-2028

1.3 Cancer Biotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.3.1 The Market Share of United States Cancer Biotherapy in Global, 2017 VS 2022 VS 2028

1.3.2 The Growth Rate of Cancer Biotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4 Cancer Biotherapy Market Dynamics

1.4.1 Cancer Biotherapy Industry Trends

1.4.2 Cancer Biotherapy Market Drivers

1.4.3 Cancer Biotherapy Market Challenges

1.4.4 Cancer Biotherapy Market Restraints

1.5 Study Objectives

1.6 Years Considered

2 Cancer Biotherapy by Type

2.1 Cancer Biotherapy Market Segment by Type

2.1.1 Monoclonal Antibodies

2.1.2 Vaccines

2.1.3 Erythropoietin

2.1.4 Colony Stimulating Factors

2.1.5 Interleukins and Interferons

2.2 Global Cancer Biotherapy Market Size by Type (2017, 2022 & 2028)

2.3 Global Cancer Biotherapy Market Size by Type (2017-2028)

2.4 United States Cancer Biotherapy Market Size by Type (2017, 2022 & 2028)

2.5 United States Cancer Biotherapy Market Size by Type (2017-2028)

3 Cancer Biotherapy by Application

3.1 Cancer Biotherapy Market Segment by Application

3.1.1 Hospitals

3.1.2 Diagnostic Laboratories

3.1.3 Research and Academic Laboratories

3.1.4 Pharmaceutical and Biotechnology Companies

3.1.5 Others

3.2 Global Cancer Biotherapy Market Size by Application (2017, 2022 & 2028)

3.3 Global Cancer Biotherapy Market Size by Application (2017-2028)

3.4 United States Cancer Biotherapy Market Size by Application (2017, 2022 & 2028)

3.5 United States Cancer Biotherapy Market Size by Application (2017-2028)

4 Global Cancer Biotherapy Competitor Landscape by Company

4.1 Global Cancer Biotherapy Market Size by Company

4.1.1 Top Global Cancer Biotherapy Companies Ranked by Revenue (2021)

4.1.2 Global Cancer Biotherapy Revenue by Player (2017-2022)

4.2 Global Cancer Biotherapy Concentration Ratio (CR)

4.2.1 Cancer Biotherapy Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Companies of Cancer Biotherapy in 2021

4.2.3 Global Cancer Biotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Cancer Biotherapy Headquarters, Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Type

4.3.1 Global Cancer Biotherapy Headquarters and Area Served

4.3.2 Global Cancer Biotherapy Companies Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Type

4.3.3 Date of International Companies Enter into Cancer Biotherapy Market

4.4 Companies Mergers & Acquisitions, Expansion Plans

4.5 United States Cancer Biotherapy Market Size by Company

4.5.1 Top Cancer Biotherapy Players in United States, Ranked by Revenue (2021)

4.5.2 United States Cancer Biotherapy Revenue by Players (2020, 2021 & 2022)

5 Global Cancer Biotherapy Market Size by Region

5.1 Global Cancer Biotherapy Market Size by Region: 2017 VS 2022 VS 2028

5.2 Global Cancer Biotherapy Market Size by Region (2017-2028)

5.2.1 Global Cancer Biotherapy Market Size by Region: 2017-2022

5.2.2 Global Cancer Biotherapy Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

6.1 North America

6.1.1 North America Cancer Biotherapy Market Size YoY Growth 2017-2028

6.1.2 North America Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 U.S.

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific Cancer Biotherapy Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific Cancer Biotherapy Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.2.12 Philippines

6.3 Europe

6.3.1 Europe Cancer Biotherapy Market Size YoY Growth 2017-2028

6.3.2 Europe Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Cancer Biotherapy Market Size YoY Growth 2017-2028

6.4.2 Latin America Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa Cancer Biotherapy Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 U.A.E

7 Company Profiles

7.1 Amgen

7.1.1 Amgen Company Details

7.1.2 Amgen Business Overview

7.1.3 Amgen Cancer Biotherapy Introduction

7.1.4 Amgen Revenue in Cancer Biotherapy Business (2017-2022)

7.1.5 Amgen Recent Development

7.2 Bristol-Myers Squibb

7.2.1 Bristol-Myers Squibb Company Details

7.2.2 Bristol-Myers Squibb Business Overview

7.2.3 Bristol-Myers Squibb Cancer Biotherapy Introduction

7.2.4 Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2017-2022)

7.2.5 Bristol-Myers Squibb Recent Development

7.3 Celgene

7.3.1 Celgene Company Details

7.3.2 Celgene Business Overview

7.3.3 Celgene Cancer Biotherapy Introduction

7.3.4 Celgene Revenue in Cancer Biotherapy Business (2017-2022)

7.3.5 Celgene Recent Development

7.4 GlaxoSmithKline

7.4.1 GlaxoSmithKline Company Details

7.4.2 GlaxoSmithKline Business Overview

7.4.3 GlaxoSmithKline Cancer Biotherapy Introduction

7.4.4 GlaxoSmithKline Revenue in Cancer Biotherapy Business (2017-2022)

7.4.5 GlaxoSmithKline Recent Development

7.5 Eli Lilly

7.5.1 Eli Lilly Company Details

7.5.2 Eli Lilly Business Overview

7.5.3 Eli Lilly Cancer Biotherapy Introduction

7.5.4 Eli Lilly Revenue in Cancer Biotherapy Business (2017-2022)

7.5.5 Eli Lilly Recent Development

8 Research Findings and Conclusion

9 Appendix

9.1 Research Methodology

9.1.1 Methodology/Research Approach

9.1.2 Data Source

9.2 Author Details

9.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Cancer Biotherapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)

Table 2. Cancer Biotherapy Market Trends

Table 3. Cancer Biotherapy Market Drivers

Table 4. Cancer Biotherapy Market Challenges

Table 5. Cancer Biotherapy Market Restraints

Table 6. Global Cancer Biotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)

Table 7. United States Cancer Biotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)

Table 8. Global Cancer Biotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)

Table 9. United States Cancer Biotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)

Table 10. Top Cancer Biotherapy Companies in Global Market, Ranking by Revenue (2021)

Table 11. Global Cancer Biotherapy Revenue by Player, (US$ Million), 2017-2022

Table 12. Global Cancer Biotherapy Revenue Share by Player, 2017-2022

Table 13. Global Cancer Biotherapy Companies Market Concentration Ratio (CR5 and HHI)

Table 14. Global Cancer Biotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biotherapy as of 2021)

Table 15. Top Players of Cancer Biotherapy in Global Market, Headquarters and Area Served

Table 16. Companies Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Type

Table 17. Date of International Companies Enter into Cancer Biotherapy Market

Table 18. Companies Mergers & Acquisitions, Expansion Plans

Table 19. Top Cancer Biotherapy Players in United States Market, Ranking by Revenue (2021)

Table 20. United States Cancer Biotherapy Revenue by Players, (US$ Million), 2020, 2021 & 2022

Table 21. United States Cancer Biotherapy Revenue Share by Players, 2020, 2021 & 2022

Table 22. Global Cancer Biotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028

Table 23. Global Cancer Biotherapy Market Size by Region (2017-2022) & (US$ Million)

Table 24. Global Cancer Biotherapy Market Size Forecast by Region (2023-2028) & (US$ Million)

Table 25. North America Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)

Table 26. Asia Pacific Cancer Biotherapy Sales in Value by Region (2017-2028) & (US$ Million)

Table 27. Europe Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)

Table 28. Latin Americaa Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)

Table 29. Middle East and Africa Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)

Table 30. Amgen Company Details

Table 31. Amgen Business Overview

Table 32. Amgen Cancer Biotherapy Product

Table 33. Amgen Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)

Table 34. Amgen Recent Development

Table 35. Bristol-Myers Squibb Company Details

Table 36. Bristol-Myers Squibb Business Overview

Table 37. Bristol-Myers Squibb Cancer Biotherapy Product

Table 38. Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)

Table 39. Bristol-Myers Squibb Recent Development

Table 40. Celgene Company Details

Table 41. Celgene Business Overview

Table 42. Celgene Cancer Biotherapy Product

Table 43. Celgene Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)

Table 44. Celgene Recent Development

Table 45. GlaxoSmithKline Company Details

Table 46. GlaxoSmithKline Business Overview

Table 47. GlaxoSmithKline Cancer Biotherapy Product

Table 48. GlaxoSmithKline Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)

Table 49. GlaxoSmithKline Recent Development

Table 50. Eli Lilly Company Details

Table 51. Eli Lilly Business Overview

Table 52. Eli Lilly Cancer Biotherapy Product

Table 53. Eli Lilly Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)

Table 54. Eli Lilly Recent Development

Table 55. Research Programs/Design for This Report

Table 56. Key Data Information from Secondary Sources

Table 57. Key Data Information from Primary Sources

List of Figures

Figure 1. Cancer Biotherapy Product Picture

Figure 2. Global Cancer Biotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028

Figure 3. Global Cancer Biotherapy Market Size 2017-2028 (US$ Million)

Figure 4. United States Cancer Biotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028

Figure 5. United States Cancer Biotherapy Market Size 2017-2028 (US$ Million)

Figure 6. United States Cancer Biotherapy Market Share in Global 2017-2028

Figure 7. Cancer Biotherapy Report Years Considered

Figure 8. Product Picture of Monoclonal Antibodies

Figure 9. Product Picture of Vaccines

Figure 10. Product Picture of Erythropoietin

Figure 11. Product Picture of Colony Stimulating Factors

Figure 12. Product Picture of Interleukins and Interferons

Figure 13. Global Cancer Biotherapy Market Share by Type in 2022 & 2028

Figure 14. Global Cancer Biotherapy Market Size by Type (2017-2028) & (US$ Million)

Figure 15. Global Cancer Biotherapy Market Share by Type (2017-2028)

Figure 16. United States Cancer Biotherapy Market Share by Type in 2022 & 2028

Figure 17. United States Cancer Biotherapy Market Size by Type (2017-2028) & (US$ Million)

Figure 18. United States Cancer Biotherapy Market Share by Type (2017-2028)

Figure 19. Product Picture of Hospitals

Figure 20. Product Picture of Diagnostic Laboratories

Figure 21. Product Picture of Research and Academic Laboratories

Figure 22. Product Picture of Pharmaceutical and Biotechnology Companies

Figure 23. Product Picture of Others

Figure 24. Global Cancer Biotherapy Market Share by Application in 2022 & 2028

Figure 25. Global Cancer Biotherapy Market Size by Application (2017-2028) & (US$ Million)

Figure 26. Global Cancer Biotherapy Market Share by Application (2017-2028)

Figure 27. United States Cancer Biotherapy Market Share by Application in 2022 & 2028

Figure 28. United States Cancer Biotherapy Market Size by Application (2017-2028) & (US$ Million)

Figure 29. United States Cancer Biotherapy Market Share by Application (2017-2028)

Figure 30. North America Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)

Figure 31. U.S. Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 32. Canada Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 33. Europe Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)

Figure 34. Germany Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 35. France Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 36. U.K. Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 37. Italy Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 38. Russia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 39. Asia-Pacific Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)

Figure 40. China Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 41. Japan Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 42. South Korea Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 43. India Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 44. Australia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 45. Taiwan Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 46. Indonesia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 47. Thailand Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 48. Malaysia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 49. Philippines Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 50. Latin America Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)

Figure 51. Mexico Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 52. Brazil Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 53. Argentina Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 54. Middle East & Africa Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)

Figure 55. Turkey Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 56. Saudi Arabia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 57. U.A.E Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 58. Amgen Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)

Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)

Figure 60. Celgene Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)

Figure 61. GlaxoSmithKline Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)

Figure 62. Eli Lilly Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global and United States Cancer Biotherapy Market Report & Forecast 2022-2028

Published Date: June 2022

Report Code: QYRE-Auto-18N5929

Global and United States Cancer Biotherapy Market Report & Forecast 2022-2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY REGION

BY COMPANY

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions